| ASSET | YEARS | % RETURN |
|---|---|---|
Mesoblast (MESO) | 2010-2021 | 9,599,900% |
QXO (QXO) | 2010-2021 | 7,075,375% |
Addex Therapeutics (ADXN) | 2010-2021 | 6,988,788.89% |
Lunai Bioworks (LNAI) | 2010-2021 | 6,204,155.32% |
Akari Therapeutics (AKTX) | 2010-2021 | 4,799,900% |
Altimmune (ALT) | 2010-2021 | 4,579,900% |
Nocera (NCRA) | 2010-2021 | 4,522,400% |
Cenntro Electric (CENN) | 2010-2021 | 3,675,328.57% |
Lexaria Bioscience (LEXX) | 2010-2021 | 3,555,782.35% |
Addentax (ATXG) | 2010-2021 | 3,214,185.71% |
Fubotv (FUBO) | 2010-2021 | 3,103,900% |
Avita Medical (RCEL) | 2010-2021 | 2,994,900% |
MDxHealth (MDXH) | 2010-2021 | 1,586,566.67% |
Beeline (BLNE) | 2010-2021 | 1,074,975.08% |
authID (AUID) | 2010-2021 | 897,820% |
A2Z Smart Technologies (AZ) | 2010-2021 | 731,656.76% |
Evogene (EVGN) | 2010-2021 | 655,900% |
CleanSpark (CLSK) | 2010-2021 | 475,900% |
Integra Resources (ITRG) | 2010-2021 | 429,900% |
Change Agents (CHGA) | 2010-2021 | 351,328.57% |
Immatics (IMTX) | 2010-2021 | 268,700% |
LiveOne (LVO) | 2010-2021 | 255,900% |
FingerMotion (FNGR) | 2010-2021 | 229,254.84% |
Guardforce AI (GFAI) | 2010-2021 | 207,592.31% |
Xpel (XPEL) | 2010-2021 | 179,584.21% |